Crossmark

DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life

Crossref DOI link: https://doi.org/10.1007/s00125-021-05513-4

Published Online: 2021-07-16

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thomas, Nicholas J. http://orcid.org/0000-0003-2513-7022
Dennis, John M. http://orcid.org/0000-0002-7171-732X
Sharp, Seth A. http://orcid.org/0000-0002-0607-9990
Kaur, Akaal

Misra, Shivani http://orcid.org/0000-0003-2886-0726
Walkey, Helen C. http://orcid.org/0000-0003-3391-0759
Johnston, Desmond G. http://orcid.org/0000-0001-9539-7108
Oliver, Nick S. http://orcid.org/0000-0003-3525-3633
Hagopian, William A. http://orcid.org/0000-0003-2979-0475
Weedon, Michael N. http://orcid.org/0000-0002-6174-6135
Patel, Kashyap A. http://orcid.org/0000-0002-9240-8104
Oram, Richard A. http://orcid.org/0000-0003-3581-8980
License Information

Text and Data Mining valid from 2021-07-16

Version of Record valid from 2021-07-16
More Information

Article History

Received: 2 December 2020

Accepted: 24 March 2021

First Online: 16 July 2021

Change Date: 26 October 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00125-021-05599-w